fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Relovair starts Phase III trial for Asthma

Written by | 16 Apr 2025

The first asthma patient has commenced treatment with Relovair (fluticasone furoate/vilanterol trifenatate) in an asthma exacerbation study, marking the start of the Phase III clinical development programme with… read more.

U of A Health Sciences researchers receive $3.4 million grant to improve asthma care in schools

Written by | 8 Jan 2025

A University of Arizona Health Sciences-led program that provides schools with asthma inhalers to help students experiencing respiratory distress will be expanded and improved thanks to a $3.4 million… read more.

The nose knows: Nasal swab detects asthma type in kids

Written by | 6 Jan 2025

Researchers at the University of Pittsburgh have developed a nasal swab test for kids that diagnoses specific asthma subtype, or endotype. This non-invasive approach could help clinicians prescribe medications more… read more.

Benralizamab shows significant potential for the treatment of asthma and COPD

Written by | 5 Dec 2024

Researchers report that an injection of benralizamab administered   during some attacks of asthma and COPD, is significantly more effective than current standard treatment with steroid tablets. The findings… read more.

High exposure to everyday chemicals linked to asthma risk in children

Written by | 27 Nov 2024

A new study from researchers at Kumamoto University sheds light on a potential link between exposure to certain everyday chemicals during pregnancy and the development of asthma in children. The… read more.

Women entering menopause later in life at greater risk for asthma

Written by | 7 Nov 2024

Many studies suggest that an earlier age at menopause is more detrimental to a woman’s health, leading to an increased risk for adverse health conditions such as heart disease, diabetes,… read more.

Airsupra demonstrated statistically significant and clinically meaningful reduction in the risk of severe exacerbations in patients with intermittent or mild persistent asthma in BATURA phase III trial

Written by | 10 Oct 2024

Positive high-level results from the BATURA Phase IIIb trial showed AstraZeneca’s Airsupra (albuterol/budesonide) met the primary endpoint, demonstrating a statistically significant and clinically meaningful reduction in the risk… read more.

Newborn breast feeding reduces risk of asthma

Written by | 28 Sep 2024

Infants fed exclusively with breast milk during their hospitalization at birth are less likely to develop asthma in early childhood, according to research presented on Sept. 27 at… read more.

Indoor allergens worsen respiratory infections in children with asthma, study finds

Written by | 15 Sep 2024

Children with asthma who are exposed to high levels of indoor allergens, such as cockroach and mouse allergens, are at an increased risk of developing respiratory viral infections… read more.

Asthma education is key to reducing deaths worldwide, say respiratory health associations

Written by | 10 May 2024

On World Asthma Day 2024 the message is clear: “Asthma Education Empowers.” The Forum of International Respiratory Societies (FIRS), of which the American Thoracic Society is a founding member, stresses the… read more.

Revealed: Mechanical damage during an asthma attack

Written by | 13 Apr 2024

In asthma, the tightening of muscles around the bronchi causes damage to the airway by squeezing and destroying epithelial cells, which promotes the airway inflammation and mucus production… read more.

Multiple air pollutants linked to asthma symptoms in children

Written by | 22 Mar 2024

Exposure to several combinations of toxic atmospheric pollutants may be triggering asthma symptoms among children, a recent analysis suggests. The study, published in the journal Science of the Total… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.